Iterum Therapeutics Q2 Earnings Preview
Source: SeekingAlpha
2025-08-04 11:31:46 ET
More on Iterum Therapeutics
- Iterum targets ORLYNVAH US launch by Q4 2025 while extending cash runway into 2026
- Iterum Therapeutics Non-GAAP EPS of -$0.10
- Seeking Alpha’s Quant Rating on Iterum Therapeutics
- Historical earnings data for Iterum Therapeutics
Read the full article on Seeking Alpha
For further details see:
Iterum Therapeutics Q2 Earnings Preview
Iterum Therapeutics plc
NASDAQ: ITRM
ITRM Trading
7.39% G/L:
$0.1772 Last:
671,637 Volume:
$0.1752 Open:
ITRM Latest News
ITRM Stock Data
$15,988,461
51,778,499
0.46%
14
N/A
Biotechnology & Life Sciences
Healthcare
IE
Dublin 1
